Banc of California, Inc. <BANC.N>: Barclays cuts target price to $22 from $23
BANC•Related News
Ceribell wins CMS NTAP for delirium monitor, worth up to $2,171 per Medicare case
CBLL•
AbbVie <ABBV.N>: Bernstein raises target price to $230 from $225
ABBV•
Twist Bioscience posts fiscal Q3 2026 earnings report and investor presentation online
TWST•
Eva Live forms Eva Defense advisory board, names Gen. Robert Brooks Brown and Ross Mandel as first members
GOAI•
Bally's closes acquisition of Sam's Town Shreveport from Boyd Gaming
BALY•